Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on September 27, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

HYDROCORTISONE VALE

Closed
SPE2DP-26-T-5267Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5267 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 7 units of Hydrocortisone Valerate Ointment, 0.2%, 15GM (NSN 6505-01-224-0178). This FDA-regulated drug is classified as a Type I Code M item with a non-extendable shelf life of 24 months. The required delivery date is April 9, 2026, with delivery, inspection, and acceptance all occurring at the destination in Fort Carson, Colorado. Quotations are due by October 5, 2026, and must be submitted via the DIBBS system. The contract mandates strict adherence to commercial packaging and packing standards, specifically requiring suitable sealed unit containers and exterior shipping containers. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and palletization must comply with RP001. The procurement incorporates various FAR and DFARS clauses, including requirements for the Buy American Act, safeguarding covered defense information, and the use of the Wide Area WorkFlow system for electronic invoicing and payment.

General Info

DLA seeks 7 units of Hydrocortisone Valerate Ointment for delivery to Fort Carson.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

CO, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this first18 pages · rfq
High

Read the document

Every page of every file, in your free workspace.

Read the document

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Sodium Chloride 0.9% Injection SupplierOpen now, due in 7 days
  • Supply of Surgical Detergent (Chlorhexidine Gluconate)Open now, due in 7 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
HYDROCORTISONE VALE
Cancel all requisitions without replacement DMLIIS Request ID 1701869 has been approved by the services to change from ACC -L to ACCY. Letitia McMillan Sign up to see this detail
HYDROCORTISONE VALERATE OINTMENT, 0.2%,15GM
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO Sign up to see this detail. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SPE2DP-26-T-5267
SECTION B
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
BRISTOL-MYERS SQUIBB CO 13811 P/N NDC00072-7800-15 GSMS INC 7A8G1 P/N NDC51672-1292-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016226101 0001 TU 7.000
NSN/MATERIAL:6505012240178
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W91M23
0010 SF BN CO A GSB
AWCF SSF
BLDG 7465 BAD TOELZ RD
FORT CARSON CO 80913-4093
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
SPE2DP-26-T-5267
SECTION B
PR: 7016226101 PRLI: 0001 CONT’D
W91M23
0010 SF BN CO A GSB
AWCF SSF
BLDG 7465 BAD TOELZ RD
FORT CARSON CO 80913-4093
US
MARKFOR
W91M23
0010 SF BN CO A GSB
AWCF SSF
BLDG 7465 BAD TOELZ RD
FORT CARSON CO 80913-4093
US
M/F: (TCN) W91M2360960214
RDD: 109
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:04/09/2026
SPE2DP-26-T-5267 NSN/Part Number: 6505-01-224-0178 Quantity: 7 TU Purchase Request: 7016226101QTY: 7 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS